Recursion Pharmaceuticals, Inc. (RXRX)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

1

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Oct-24 6:30 PM View:	01-Oct-24 Grant 0	Dar Zavain Director		Recursion Pharmaceuticals, Inc. - RXRX	2% 104.0K to 106.22K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 6:26 PM View:	15-Nov-24 Payment of Exercise ($88.22K)	Larson Tina Marriott President and COO		Recursion Pharmaceuticals, Inc. - RXRX	(3%) 521.14K to 506.85K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 6:29 PM View:	01-Oct-24 Grant 0	Li Dean Y Director		Recursion Pharmaceuticals, Inc. - RXRX	0% 3.19M to 3.19M	0	0	--	--	Show Txns Hide Txns

19-Nov-24 6:26 PM View:	15-Nov-24 Payment of Exercise ($73.71K)	Secora Michael Chief Financial Officer		Recursion Pharmaceuticals, Inc. - RXRX	10% 1.35M to 1.49M	0	0	--	--	Show Txns Hide Txns

14-Nov-24 7:19 PM View:	12-Nov-24 Sale (Planned) ($87.46K)	Borgeson Blake Director		Recursion Pharmaceuticals, Inc. - RXRX	(1%) 7.13M to 7.07M	0	0	--	--	Show Txns Hide Txns

19-Nov-24 6:26 PM View:	15-Nov-24 Payment of Exercise ($160.69K)	Gibson Christopher Chief Executive Officer Director		Recursion Pharmaceuticals, Inc. - RXRX	1% 732.66K to 736.63K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 6:26 PM View:	15-Nov-24 Payment of Exercise ($25.85K)	Mauro David J Chief Medical Officer		Recursion Pharmaceuticals, Inc. - RXRX	(2%) 229.62K to 225.43K	0	0	--	--	Show Txns Hide Txns